|
G |
Ager |
advanced glycosylation end product-specific receptor |
multiple interactions |
ISO |
[Tobacco Smoke Pollution results in increased abundance of Cotinine] which affects the methylation of AGER gene |
CTD |
PMID:34009014 |
|
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
|
|
G |
Ahrr |
aryl-hydrocarbon receptor repressor |
affects methylation |
ISO |
Cotinine affects the methylation of AHRR gene |
CTD |
PMID:22851337 |
|
NCBI chr 1:28,993,634...29,088,673
Ensembl chr 1:28,993,634...29,088,673
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
increases phosphorylation multiple interactions |
ISO |
Cotinine results in increased phosphorylation of AKT1 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Cotinine results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:22687995 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Bsg |
basigin |
multiple interactions |
ISO |
[Tobacco Smoke Pollution results in increased abundance of Cotinine] which affects the methylation of BSG gene |
CTD |
PMID:34009014 |
|
NCBI chr 7:9,993,170...10,000,387
Ensembl chr 7:9,993,170...10,000,387
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
Cotinine inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein] |
CTD |
PMID:22687995 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
multiple interactions |
ISO |
Cotinine inhibits the reaction [Doxorubicin results in increased activity of CASP7 protein] |
CTD |
PMID:22687995 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Ccnd1 |
cyclin D1 |
increases expression |
ISO |
Cotinine results in increased expression of CCND1 protein |
CTD |
PMID:31678612 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cd68 |
Cd68 molecule |
multiple interactions |
EXP |
[Nicotine results in increased abundance of Cotinine] which results in increased expression of CD68 mRNA |
CTD |
PMID:29617909 |
|
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
multiple interactions |
EXP |
[Nicotine results in increased abundance of Cotinine] which results in increased expression of CEBPA protein |
CTD |
PMID:29617909 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
multiple interactions |
EXP |
[Nicotine results in increased abundance of Cotinine] which results in increased expression of CEBPB mRNA |
CTD |
PMID:29617909 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Chrna7 |
cholinergic receptor nicotinic alpha 7 subunit |
increases response to substance multiple interactions |
ISO |
CHRNA7 protein mutant form results in increased susceptibility to Cotinine Cotinine binds to and results in increased activity of CHRNA7 protein |
CTD |
PMID:10082212 |
|
NCBI chr 1:116,711,559...116,837,269
Ensembl chr 1:116,714,711...116,837,240
|
|
G |
Cntnap2 |
contactin associated protein 2 |
affects methylation |
ISO |
Cotinine affects the methylation of CNTNAP2 gene |
CTD |
PMID:22851337 |
|
NCBI chr 4:74,109,455...76,366,434
Ensembl chr 4:74,109,472...76,362,027
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
affects methylation |
ISO |
Cotinine affects the methylation of CYP1A1 gene |
CTD |
PMID:22851337 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases activity decreases activity |
ISO |
Cotinine results in increased activity of CYP1A2 protein Cotinine results in decreased activity of CYP1A2 protein |
CTD |
PMID:15916432 PMID:16203240 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
increases abundance multiple interactions |
EXP |
CYP2B1 protein results in increased abundance of Cotinine [Nicotine results in increased expression of CYP2B1 protein] which results in increased abundance of Cotinine |
CTD |
PMID:10799646 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
increases chemical synthesis |
ISO |
CYP2B6 protein results in increased chemical synthesis of Cotinine |
CTD |
PMID:12488541 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Dcx |
doublecortin |
multiple interactions |
ISO |
[diethyl phosphate co-treated with Cotinine co-treated with bis(2,3,3,3-tetrachloropropyl) ether co-treated with Mercury co-treated with Selenium] results in increased expression of DCX mRNA |
CTD |
PMID:37914285 |
|
NCBI chr X:107,430,767...107,573,612
Ensembl chr X:107,430,767...107,507,476
|
|
G |
Dlgap2 |
DLG associated protein 2 |
multiple interactions |
ISO |
[Tobacco Smoke Pollution results in increased abundance of Cotinine] which affects the methylation of DLGAP2 gene |
CTD |
PMID:34009014 |
|
NCBI chr16:74,786,771...75,496,402
Ensembl chr16:74,791,509...75,496,407
|
|
G |
Ext1 |
exostosin glycosyltransferase 1 |
affects methylation |
ISO |
Cotinine affects the methylation of EXT1 gene |
CTD |
PMID:22851337 |
|
NCBI chr 7:84,375,769...84,654,625
Ensembl chr 7:84,375,784...84,655,357
|
|
G |
Fhit |
fragile histidine triad diadenosine triphosphatase |
multiple interactions |
ISO |
[Tobacco Smoke Pollution results in increased abundance of Cotinine] which affects the methylation of FHIT gene |
CTD |
PMID:34009014 |
|
NCBI chr15:13,935,029...15,442,620
Ensembl chr15:13,934,995...15,442,340
|
|
G |
Gfi1 |
growth factor independent 1 transcriptional repressor |
affects methylation |
ISO |
Cotinine affects the methylation of GFI1 gene |
CTD |
PMID:22851337 |
|
NCBI chr14:2,040,576...2,056,874
Ensembl chr14:2,042,434...2,051,814
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
EXP |
[Nicotine results in increased abundance of Cotinine] which results in increased expression of IL1B mRNA |
CTD |
PMID:29617909 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
EXP |
[Nicotine results in increased abundance of Cotinine] which results in increased expression of IL6 mRNA |
CTD |
PMID:29617909 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Map2 |
microtubule-associated protein 2 |
multiple interactions |
ISO |
[diethyl phosphate co-treated with Cotinine co-treated with bis(2,3,3,3-tetrachloropropyl) ether co-treated with Mercury co-treated with Selenium] results in increased expression of MAP2 mRNA |
CTD |
PMID:37914285 |
|
NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
decreases phosphorylation |
ISO |
Cotinine results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:31678612 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
decreases phosphorylation |
ISO |
Cotinine results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:31678612 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
increases expression |
EXP |
Cotinine results in increased expression of MKI67 protein |
CTD |
PMID:31678612 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Myo1g |
myosin IG |
affects methylation |
ISO |
Cotinine affects the methylation of MYO1G gene |
CTD |
PMID:22851337 |
|
NCBI chr14:81,386,701...81,401,843
Ensembl chr14:81,386,701...81,401,843
|
|
G |
Nat1 |
N-acetyltransferase 1 |
multiple interactions affects abundance |
ISO |
NAT1 gene polymorphism affects the reaction [Tobacco Smoke Pollution results in increased abundance of Cotinine] NAT1 gene polymorphism affects the abundance of Cotinine |
CTD |
PMID:25156213 |
|
NCBI chr16:22,218,217...22,238,516
Ensembl chr16:22,208,194...22,238,520
|
|
G |
Pax6 |
paired box 6 |
multiple interactions |
ISO |
[diethyl phosphate co-treated with Cotinine co-treated with bis(2,3,3,3-tetrachloropropyl) ether co-treated with Mercury co-treated with Selenium] results in increased expression of PAX6 mRNA |
CTD |
PMID:37914285 |
|
NCBI chr 3:92,128,772...92,157,022
Ensembl chr 3:92,135,637...92,157,014
|
|
G |
Pnpla2 |
patatin-like phospholipase domain containing 2 |
multiple interactions |
EXP |
[Nicotine results in increased abundance of Cotinine] which results in increased expression of PNPLA2 mRNA; [Nicotine results in increased abundance of Cotinine] which results in increased expression of PNPLA2 protein |
CTD |
PMID:29617909 |
|
NCBI chr 1:196,552,723...196,557,805
Ensembl chr 1:196,552,723...196,557,805
|
|
G |
Prkg1 |
protein kinase cGMP-dependent 1 |
multiple interactions |
ISO |
[Tobacco Smoke Pollution results in increased abundance of Cotinine] which affects the methylation of PRKG1 gene |
CTD |
PMID:34009014 |
|
NCBI chr 1:228,409,605...229,638,794
Ensembl chr 1:228,408,947...229,639,080
|
|
G |
Rbfox3 |
RNA binding fox-1 homolog 3 |
multiple interactions |
ISO |
[diethyl phosphate co-treated with Cotinine co-treated with bis(2,3,3,3-tetrachloropropyl) ether co-treated with Mercury co-treated with Selenium] results in increased expression of RBFOX3 mRNA |
CTD |
PMID:37914285 |
|
NCBI chr10:103,720,355...104,157,277
Ensembl chr10:103,720,636...104,156,935
|
|
G |
Runx1 |
RUNX family transcription factor 1 |
affects methylation |
ISO |
Cotinine affects the methylation of RUNX1 gene |
CTD |
PMID:22851337 |
|
NCBI chr11:31,839,880...32,074,427
Ensembl chr11:31,843,764...32,074,542
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions |
EXP |
[Nicotine results in increased abundance of Cotinine] which results in increased expression of SOD1 mRNA; [Nicotine results in increased abundance of Cotinine] which results in increased expression of SOD1 protein |
CTD |
PMID:29617909 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions |
EXP |
[Nicotine results in increased abundance of Cotinine] which results in increased expression of SOD2 protein |
CTD |
PMID:29617909 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
multiple interactions |
EXP |
[Nicotine results in increased abundance of Cotinine] which results in increased expression of SREBF1 mRNA |
CTD |
PMID:29617909 |
|
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
increases phosphorylation |
ISO |
Cotinine results in increased phosphorylation of STAT3 protein |
CTD |
PMID:31678612 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP |
[Nicotine results in increased abundance of Cotinine] which results in increased expression of TNF mRNA |
CTD |
PMID:29617909 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Ttc7b |
tetratricopeptide repeat domain 7B |
affects methylation |
ISO |
Cotinine affects the methylation of TTC7B gene |
CTD |
PMID:22851337 |
|
NCBI chr 6:119,587,389...119,799,167
Ensembl chr 6:119,587,390...119,799,330
|
|
G |
Ugt1a5 |
UDP glucuronosyltransferase family 1 member A5 |
increases glucuronidation |
ISO |
UGT1A4 protein results in increased glucuronidation of Cotinine |
CTD |
PMID:14570768 PMID:16141602 |
|
NCBI chr 9:88,762,250...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
increases glucuronidation |
ISO |
UGT1A9 protein results in increased glucuronidation of Cotinine |
CTD |
PMID:16141602 |
|
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
|
G |
Dek |
DEK proto-oncogene |
multiple interactions |
ISO |
DEK protein results in decreased chemical synthesis of and results in increased uptake of Pyrrolidonecarboxylic Acid |
CTD |
PMID:28558019 |
|
NCBI chr17:17,580,804...17,602,825
Ensembl chr17:17,580,843...17,602,808
|
|
G |
Ins2 |
insulin 2 |
multiple interactions |
ISO |
[1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased abundance of Pyrrolidonecarboxylic Acid analog |
CTD |
PMID:26820058 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
|
G |
Ces1d |
carboxylesterase 1D |
increases hydrolysis |
ISO |
CES1 protein results in increased hydrolysis of aniracetam |
CTD |
PMID:9300133 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Ces2h |
carboxylesterase 2H |
increases hydrolysis |
ISO |
CES2 protein results in increased hydrolysis of aniracetam |
CTD |
PMID:9300133 |
|
NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
|
|
|
G |
Crh |
corticotropin releasing hormone |
increases expression |
EXP |
Doxapram results in increased expression of CRH mRNA; Doxapram results in increased expression of CRH protein |
CTD |
PMID:16269353 |
|
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
|
|
G |
Prl |
prolactin |
increases expression |
ISO |
Doxapram results in increased expression of PRL protein |
CTD |
PMID:15741000 |
|
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions increases expression increases transport decreases activity |
EXP ISO |
Amino Acids, Peptides, and Proteins inhibits the reaction [Levetiracetam results in increased expression of ABCB1 protein] ABCB1A protein results in increased transport of Levetiracetam Levetiracetam results in decreased activity of ABCB1 protein |
CTD |
PMID:17045309 PMID:18408562 PMID:18473823 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
increases expression |
EXP |
Levetiracetam results in increased expression of ABCC1 protein |
CTD |
PMID:18473823 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
increases expression |
EXP |
Levetiracetam results in increased expression of ABCC2 protein |
CTD |
PMID:18473823 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Acvrl1 |
activin A receptor like type 1 |
decreases expression |
EXP |
Levetiracetam results in decreased expression of ACVRL1 mRNA |
CTD |
PMID:20345932 |
|
NCBI chr 7:132,239,200...132,256,592
Ensembl chr 7:132,239,729...132,256,591
|
|
G |
Arhgef1 |
Rho guanine nucleotide exchange factor 1 |
decreases expression |
EXP |
Levetiracetam results in decreased expression of ARHGEF1 mRNA |
CTD |
PMID:20345932 |
|
NCBI chr 1:80,499,026...80,520,954
Ensembl chr 1:80,499,131...80,520,953
|
|
G |
Atg7 |
autophagy related 7 |
decreases expression multiple interactions |
EXP |
Levetiracetam results in decreased expression of ATG7 protein Quercetin inhibits the reaction [Levetiracetam results in decreased expression of ATG7 protein] |
CTD |
PMID:37098359 |
|
NCBI chr 4:147,718,663...147,925,656
Ensembl chr 4:147,718,752...147,925,593
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions |
EXP |
Levetiracetam results in decreased expression of BCL2 protein Quercetin inhibits the reaction [Levetiracetam results in decreased expression of BCL2 protein] |
CTD |
PMID:37098359 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Cacnb1 |
calcium voltage-gated channel auxiliary subunit beta 1 |
decreases expression |
EXP |
Levetiracetam results in decreased expression of CACNB1 mRNA |
CTD |
PMID:20345932 |
|
NCBI chr10:82,998,182...83,018,838
Ensembl chr10:82,998,182...83,018,694
|
|
G |
Casp3 |
caspase 3 |
increases activity multiple interactions |
EXP |
Levetiracetam results in increased activity of CASP3 protein Quercetin inhibits the reaction [Levetiracetam results in increased activity of CASP3 protein] |
CTD |
PMID:37098359 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cat |
catalase |
multiple interactions decreases expression |
ISO EXP |
Levetiracetam inhibits the reaction [Pilocarpine results in increased activity of CAT protein] Quercetin inhibits the reaction [Levetiracetam results in decreased expression of CAT protein] |
CTD |
PMID:17205390 PMID:37098359 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccnh |
cyclin H |
increases expression |
EXP |
Levetiracetam results in increased expression of CCNH mRNA |
CTD |
PMID:20345932 |
|
NCBI chr 2:15,835,064...15,855,648
Ensembl chr 2:15,834,833...15,855,819
|
|
G |
Chrm2 |
cholinergic receptor, muscarinic 2 |
increases activity decreases expression |
ISO |
Levetiracetam results in increased activity of CHRM2 protein Levetiracetam results in decreased expression of CHRM2 protein |
CTD |
PMID:15967574 |
|
NCBI chr 4:65,015,408...65,149,104
Ensembl chr 4:65,014,144...65,149,103
|
|
G |
Cxcr3 |
C-X-C motif chemokine receptor 3 |
increases expression |
EXP |
Levetiracetam results in increased expression of CXCR3 mRNA |
CTD |
PMID:20345932 |
|
NCBI chr X:66,844,318...66,846,969
Ensembl chr X:66,844,318...66,846,969
|
|
G |
Cycs |
cytochrome c, somatic |
increases expression multiple interactions |
EXP |
Levetiracetam results in increased expression of CYCS protein Quercetin inhibits the reaction [Levetiracetam results in increased expression of CYCS protein] |
CTD |
PMID:37098359 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
decreases expression |
ISO |
Levetiracetam results in decreased expression of CYP17A1 mRNA |
CTD |
PMID:19566492 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
decreases expression |
ISO |
Levetiracetam results in decreased expression of CYP19A1 mRNA |
CTD |
PMID:19566492 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Dao |
D-amino-acid oxidase |
increases expression |
EXP |
Levetiracetam results in increased expression of DAO mRNA |
CTD |
PMID:20345932 |
|
NCBI chr12:42,592,342...42,613,046
Ensembl chr12:42,592,343...42,612,741
|
|
G |
Dbp |
D-box binding PAR bZIP transcription factor |
decreases expression |
EXP |
Levetiracetam results in decreased expression of DBP mRNA |
CTD |
PMID:20345932 |
|
NCBI chr 1:96,175,796...96,180,745
Ensembl chr 1:96,175,440...96,180,745
|
|
G |
Des |
desmin |
increases expression |
EXP |
Levetiracetam results in increased expression of DES mRNA |
CTD |
PMID:20345932 |
|
NCBI chr 9:76,850,979...76,858,695
Ensembl chr 9:76,850,982...76,858,699
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
multiple interactions increases expression |
EXP |
Quercetin inhibits the reaction [Levetiracetam results in increased expression of GJA1 protein] |
CTD |
PMID:37098359 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Gle1 |
GLE1 RNA export mediator |
increases expression |
EXP |
Levetiracetam results in increased expression of GLE1 mRNA |
CTD |
PMID:20345932 |
|
NCBI chr 3:13,209,312...13,237,018
Ensembl chr 3:13,209,322...13,237,379
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
increases activity |
EXP |
Levetiracetam results in increased activity of GOT1 protein |
CTD |
PMID:37572749 |
|
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
increases activity |
EXP |
Levetiracetam results in increased activity of GPT protein |
CTD |
PMID:37572749 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
decreases activity decreases expression multiple interactions |
EXP |
Levetiracetam results in decreased activity of GPX1 protein Levetiracetam results in decreased expression of GPX1 protein Quercetin inhibits the reaction [Levetiracetam results in decreased expression of GPX1 protein] |
CTD |
PMID:37098359 PMID:37572749 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Hcn2 |
hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2 |
decreases expression |
EXP |
Levetiracetam results in decreased expression of HCN2 mRNA |
CTD |
PMID:20345932 |
|
NCBI chr 7:9,969,801...9,988,839
Ensembl chr 7:9,970,368...9,988,841
|
|
G |
Hdac10 |
histone deacetylase 10 |
decreases expression |
EXP |
Levetiracetam results in decreased expression of HDAC10 mRNA |
CTD |
PMID:20345932 |
|
NCBI chr 7:120,199,126...120,205,850
Ensembl chr 7:120,199,129...120,204,228
|
|
G |
Hmox1 |
heme oxygenase 1 |
decreases expression |
EXP |
Levetiracetam results in decreased expression of HMOX1 protein |
CTD |
PMID:37098359 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hmox2 |
heme oxygenase 2 |
multiple interactions |
EXP |
Quercetin inhibits the reaction [Levetiracetam results in decreased expression of HMOX2 protein] |
CTD |
PMID:37098359 |
|
NCBI chr10:10,797,076...10,831,178
Ensembl chr10:10,797,055...10,831,148
|
|
G |
Hsd3b2 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
decreases expression |
ISO |
Levetiracetam results in decreased expression of HSD3B2 mRNA |
CTD |
PMID:19566492 |
|
NCBI chr 2:186,095,897...186,105,354
Ensembl chr 2:186,095,897...186,101,852
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases activity |
EXP |
Quercetin inhibits the reaction [Levetiracetam results in increased activity of IL1B protein] |
CTD |
PMID:37098359 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Kcna4 |
potassium voltage-gated channel subfamily A member 4 |
increases expression |
EXP |
Levetiracetam results in increased expression of KCNA4 mRNA |
CTD |
PMID:20345932 |
|
NCBI chr 3:93,756,399...93,778,004
Ensembl chr 3:93,756,446...93,769,162
|
|
G |
Kctd3 |
potassium channel tetramerization domain containing 3 |
increases expression |
EXP |
Levetiracetam results in increased expression of KCTD3 mRNA |
CTD |
PMID:20345932 |
|
NCBI chr13:100,510,193...100,548,765
Ensembl chr13:100,510,195...100,548,718
|
|
G |
Khdrbs2 |
KH RNA binding domain containing, signal transduction associated 2 |
increases expression |
EXP |
Levetiracetam results in increased expression of KHDRBS2 mRNA |
CTD |
PMID:20345932 |
|
NCBI chr 9:34,447,023...34,953,684
Ensembl chr 9:34,447,056...34,915,530
|
|
G |
Lap3 |
leucine aminopeptidase 3 |
increases expression |
EXP |
Levetiracetam results in increased expression of LAP3 mRNA |
CTD |
PMID:20345932 |
|
NCBI chr14:65,608,375...65,627,359
Ensembl chr14:65,608,376...65,627,359
|
|
G |
Lsm1 |
LSM1 homolog, mRNA degradation associated |
increases expression |
EXP |
Levetiracetam results in increased expression of LSM1 mRNA |
CTD |
PMID:20345932 |
|
NCBI chr16:66,277,345...66,288,852
Ensembl chr16:66,277,345...66,288,852
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
multiple interactions decreases expression |
EXP |
Quercetin inhibits the reaction [Levetiracetam results in decreased expression of MTOR protein] |
CTD |
PMID:37098359 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Nap1l2 |
nucleosome assembly protein 1-like 2 |
increases expression |
EXP |
Levetiracetam results in increased expression of NAP1L2 mRNA |
CTD |
PMID:20345932 |
|
NCBI chr X:68,174,051...68,176,449
Ensembl chr X:68,173,987...68,176,666
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions decreases expression |
EXP |
Quercetin inhibits the reaction [Levetiracetam results in decreased expression of NFE2L2 protein] |
CTD |
PMID:37098359 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Ngly1 |
N-glycanase 1 |
increases expression |
EXP |
Levetiracetam results in increased expression of NGLY1 mRNA |
CTD |
PMID:20345932 |
|
NCBI chr15:9,153,738...9,210,228
Ensembl chr15:9,153,738...9,204,630
|
|
G |
Nox1 |
NADPH oxidase 1 |
multiple interactions decreases expression |
EXP |
Quercetin inhibits the reaction [Levetiracetam results in decreased expression of NOX1 protein] |
CTD |
PMID:37098359 |
|
NCBI chr X:97,279,058...97,332,291
Ensembl chr X:97,279,056...97,302,236
|
|
G |
Phldb1 |
pleckstrin homology-like domain, family B, member 1 |
decreases expression |
EXP |
Levetiracetam results in decreased expression of PHLDB1 mRNA |
CTD |
PMID:20345932 |
|
NCBI chr 8:45,003,543...45,051,541
Ensembl chr 8:45,003,538...45,051,522
|
|
G |
Pon1 |
paraoxonase 1 |
affects activity |
ISO |
Levetiracetam affects the activity of PON1 protein |
CTD |
PMID:28032682 |
|
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
|
|
G |
Prkx |
protein kinase cAMP-dependent X-linked catalytic subunit |
increases expression |
EXP |
Levetiracetam results in increased expression of PRKX mRNA |
CTD |
PMID:20345932 |
|
NCBI chr X:41,823,349...41,866,844
Ensembl chr X:41,823,355...41,866,669
|
|
G |
Psip1 |
PC4 and SRSF1 interacting protein 1 |
increases expression |
EXP |
Levetiracetam results in increased expression of PSIP1 mRNA |
CTD |
PMID:20345932 |
|
NCBI chr 5:97,847,010...97,879,280
Ensembl chr 5:97,847,015...97,879,257
|
|
G |
Serinc1 |
serine incorporator 1 |
increases expression |
EXP |
Levetiracetam results in increased expression of SERINC1 mRNA |
CTD |
PMID:20345932 |
|
NCBI chr20:36,850,062...36,868,999
Ensembl chr20:36,850,076...36,896,691
|
|
G |
Slc23a2 |
solute carrier family 23 member 2 |
increases expression |
EXP |
Levetiracetam results in increased expression of SLC23A2 mRNA |
CTD |
PMID:20345932 |
|
NCBI chr 3:119,302,651...119,395,289
Ensembl chr 3:119,302,666...119,460,343
|
|
G |
Slc4a7 |
solute carrier family 4 member 7 |
increases expression |
EXP |
Levetiracetam results in increased expression of SLC4A7 mRNA |
CTD |
PMID:20345932 |
|
NCBI chr15:10,585,307...10,664,780
Ensembl chr15:10,588,979...10,664,781
|
|
G |
Smc2 |
structural maintenance of chromosomes 2 |
increases expression |
EXP |
Levetiracetam results in increased expression of SMC2 mRNA |
CTD |
PMID:20345932 |
|
NCBI chr 5:66,806,882...66,853,478
Ensembl chr 5:66,807,011...66,853,242
|
|
G |
Sod1 |
superoxide dismutase 1 |
decreases activity multiple interactions decreases expression |
EXP |
Levetiracetam results in decreased activity of SOD1 protein Quercetin inhibits the reaction [Levetiracetam results in decreased expression of SOD1 protein] |
CTD |
PMID:37098359 PMID:37572749 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Star |
steroidogenic acute regulatory protein |
decreases expression |
ISO |
Levetiracetam results in decreased expression of STAR mRNA |
CTD |
PMID:19566492 |
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Tent2 |
terminal nucleotidyltransferase 2 |
increases expression |
EXP |
Levetiracetam results in increased expression of TENT2 mRNA |
CTD |
PMID:20345932 |
|
NCBI chr 2:24,380,135...24,432,099
Ensembl chr 2:24,380,225...24,432,099
|
|
G |
Tnf |
tumor necrosis factor |
increases activity multiple interactions |
EXP |
Levetiracetam results in increased activity of TNF protein Quercetin inhibits the reaction [Levetiracetam results in increased activity of TNF protein] |
CTD |
PMID:37098359 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
increases activity multiple interactions |
EXP |
Levetiracetam results in increased activity of TP53 protein Quercetin inhibits the reaction [Levetiracetam results in increased activity of TP53 protein] |
CTD |
PMID:37098359 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Trdmt1 |
tRNA aspartic acid methyltransferase 1 |
decreases expression |
EXP |
Levetiracetam results in decreased expression of TRDMT1 mRNA |
CTD |
PMID:20345932 |
|
NCBI chr17:76,601,966...76,646,104
Ensembl chr17:76,610,543...76,645,439
|
|
G |
Vars2 |
valyl-tRNA synthetase 2, mitochondrial |
decreases expression |
EXP |
Levetiracetam results in decreased expression of VARS2 mRNA |
CTD |
PMID:20345932 |
|
NCBI chr20:3,077,132...3,087,994
Ensembl chr20:3,077,132...3,087,994
|
|
G |
Xrcc1 |
X-ray repair cross complementing 1 |
decreases expression |
EXP |
Levetiracetam results in decreased expression of XRCC1 mRNA |
CTD |
PMID:20345932 |
|
NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701
|
|
G |
Zfp266 |
zinc finger protein 266 |
increases expression |
EXP |
Levetiracetam results in increased expression of ZFP266 mRNA |
CTD |
PMID:20345932 |
|
NCBI chr 8:19,030,766...19,061,381
Ensembl chr 8:19,030,768...19,060,937
|
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
multiple interactions |
EXP |
[N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of ABCC2 mRNA |
CTD |
PMID:22037397 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
multiple interactions |
EXP |
[N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of ABCC3 mRNA |
CTD |
PMID:22037397 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
EXP |
[N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of AKT1 mRNA |
CTD |
PMID:22037397 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Akt2 |
AKT serine/threonine kinase 2 |
multiple interactions |
EXP |
[N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of AKT2 mRNA |
CTD |
PMID:22037397 |
|
NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
|
|
G |
Bcar1 |
BCAR1 scaffold protein, Cas family member |
multiple interactions |
EXP |
[N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of BCAR1 mRNA |
CTD |
PMID:22037397 |
|
NCBI chr19:39,679,215...39,713,907
Ensembl chr19:39,679,204...39,713,907
|
|
G |
Capn1 |
calpain 1 |
multiple interactions |
EXP |
[N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of CAPN1 mRNA |
CTD |
PMID:22037397 |
|
NCBI chr 1:203,275,912...203,300,848
Ensembl chr 1:203,277,344...203,300,177
|
|
G |
Crk |
CRK proto-oncogene, adaptor protein |
multiple interactions |
EXP |
[N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of CRK mRNA |
CTD |
PMID:22037397 |
|
NCBI chr10:60,530,469...60,556,703
Ensembl chr10:60,530,464...60,553,406
|
|
G |
Csnk1d |
casein kinase 1, delta |
multiple interactions |
EXP |
[N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of CSNK1D mRNA |
CTD |
PMID:22037397 |
|
NCBI chr10:106,221,992...106,256,620
Ensembl chr10:106,221,992...106,256,614
|
|
G |
Csnk1e |
casein kinase 1, epsilon |
multiple interactions |
EXP |
[N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of CSNK1E mRNA |
CTD |
PMID:22037397 |
|
NCBI chr 7:110,983,322...111,006,926
Ensembl chr 7:110,983,318...111,006,794
|
|
G |
Csnk2a1 |
casein kinase 2 alpha 1 |
multiple interactions |
EXP |
[N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of CSNK2A1 mRNA |
CTD |
PMID:22037397 |
|
NCBI chr 3:140,709,984...140,756,757
Ensembl chr 3:140,709,991...140,756,696
|
|
G |
Csnk2a2 |
casein kinase 2 alpha 2 |
multiple interactions |
EXP |
[N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of CSNK2A2 mRNA |
CTD |
PMID:22037397 |
|
NCBI chr19:9,556,443...9,596,080
Ensembl chr19:9,556,260...9,596,080
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
multiple interactions |
EXP |
[N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of CYP2B1 mRNA |
CTD |
PMID:22037397 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
multiple interactions |
EXP |
[N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of CYP3A23-3A1 mRNA |
CTD |
PMID:22037397 |
|
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
multiple interactions |
EXP |
[N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of CYP3A9 mRNA |
CTD |
PMID:22037397 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Ddr1 |
discoidin domain receptor tyrosine kinase 1 |
multiple interactions |
EXP |
[N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of DDR1 mRNA |
CTD |
PMID:22037397 |
|
NCBI chr20:3,042,494...3,064,442
Ensembl chr20:3,044,320...3,064,468
|
|
G |
Foxg1 |
forkhead box G1 |
multiple interactions |
EXP |
[N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of FOXG1 mRNA |
CTD |
PMID:22037397 |
|
NCBI chr 6:66,674,797...66,677,611
Ensembl chr 6:66,666,587...66,678,607
|
|
G |
Hdac1 |
histone deacetylase 1 |
multiple interactions |
EXP |
[N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which affects the expression of HDAC1 mRNA |
CTD |
PMID:22037397 |
|
NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111
|
|
G |
Ilk |
integrin-linked kinase |
multiple interactions |
EXP |
[N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of ILK mRNA |
CTD |
PMID:22037397 |
|
NCBI chr 1:160,088,839...160,095,140
Ensembl chr 1:160,088,897...160,095,140
|
|
G |
Lef1 |
lymphoid enhancer binding factor 1 |
multiple interactions |
EXP |
[N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of LEF1 mRNA |
CTD |
PMID:22037397 |
|
NCBI chr 2:219,666,549...219,779,815
Ensembl chr 2:219,666,592...219,779,794
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
multiple interactions |
EXP |
[N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which affects the expression of MDM2 mRNA |
CTD |
PMID:22037397 |
|
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
|
|
G |
Pik3r2 |
phosphoinositide-3-kinase regulatory subunit 2 |
multiple interactions |
EXP |
[N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of PIK3R2 mRNA |
CTD |
PMID:22037397 |
|
NCBI chr16:18,665,517...18,674,067
Ensembl chr16:18,665,457...18,674,065
|
|
G |
Ppp2r1a |
protein phosphatase 2 scaffold subunit A alpha |
multiple interactions |
EXP |
[N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of PPP2R1A mRNA |
CTD |
PMID:22037397 |
|
NCBI chr 1:60,540,223...60,559,467
Ensembl chr 1:60,540,194...60,560,129
|
|
G |
Slc5a5 |
solute carrier family 5 member 5 |
multiple interactions |
EXP |
[N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which affects the expression of SLC5A5 mRNA |
CTD |
PMID:22037397 |
|
NCBI chr16:18,546,709...18,556,698
Ensembl chr16:18,546,709...18,556,697
|
|
G |
Tcf3 |
transcription factor 3 |
multiple interactions |
EXP |
[N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of TCF3 mRNA |
CTD |
PMID:22037397 |
|
NCBI chr 7:9,280,571...9,302,315
Ensembl chr 7:9,280,571...9,302,314
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
EXP |
[N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of TGFB1 mRNA |
CTD |
PMID:22037397 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tgfbr2 |
transforming growth factor, beta receptor 2 |
multiple interactions |
EXP |
[N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of TGFBR2 mRNA |
CTD |
PMID:22037397 |
|
NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:115,794,537...115,883,228
|
|
G |
Tpo |
thyroid peroxidase |
multiple interactions |
EXP |
[N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of TPO mRNA |
CTD |
PMID:22037397 |
|
NCBI chr 6:46,698,402...46,768,199
Ensembl chr 6:46,698,414...46,768,199
|
|
G |
Tshb |
thyroid stimulating hormone subunit beta |
multiple interactions |
EXP |
[N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of TSHB protein |
CTD |
PMID:22037397 |
|
NCBI chr 2:190,224,676...190,229,559
Ensembl chr 2:190,224,676...190,229,559
|
|
G |
Ugt2b1 |
UDP glucuronosyltransferase 2 family, polypeptide B1 |
multiple interactions |
EXP |
[N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of UGT2B1 mRNA |
CTD |
PMID:22037397 |
|
NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986
|
|
G |
Wnt4 |
Wnt family member 4 |
multiple interactions |
EXP |
[N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of WNT4 mRNA |
CTD |
PMID:22037397 |
|
NCBI chr 5:149,513,573...149,535,415
Ensembl chr 5:149,514,018...149,532,859
|
|
|
G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
multiple interactions |
ISO |
Rolipram promotes the reaction [ADCYAP1 protein affects the secretion of Acids] |
CTD |
PMID:20388963 |
|
NCBI chr 9:113,102,632...113,122,500
Ensembl chr 9:113,103,718...113,109,773
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions increases phosphorylation |
EXP |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Rolipram promotes the reaction [Nitroprusside results in increased phosphorylation of AKT1 protein]]; RAPGEF3 mutant form inhibits the reaction [Rolipram results in increased phosphorylation of AKT1 protein]; Rolipram promotes the reaction [Nitroprusside results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:18276108 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Ap2m1 |
adaptor related protein complex 2 subunit mu 1 |
multiple interactions |
ISO |
Rolipram inhibits the reaction [NTRK2 protein binds to AP2M1 protein] |
CTD |
PMID:31631060 |
|
NCBI chr11:80,355,307...80,364,218
Ensembl chr11:80,328,041...80,364,140
|
|
G |
Areg |
amphiregulin |
increases expression |
ISO |
Rolipram results in increased expression of AREG mRNA |
CTD |
PMID:15284208 |
|
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
EXP |
Rolipram inhibits the reaction [Manganese results in increased expression of BAX protein] |
CTD |
PMID:31161640 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
EXP |
[Rolipram co-treated with Pentoxifylline] inhibits the reaction [Streptozocin results in increased expression of BCL2 protein]; Rolipram inhibits the reaction [Manganese results in decreased expression of BCL2 protein] |
CTD |
PMID:31161640 PMID:37431890 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions increases expression |
EXP |
Rolipram inhibits the reaction [Manganese results in decreased expression of BDNF protein]; Rolipram promotes the reaction [Imipramine results in increased expression of BDNF mRNA] Rolipram results in increased expression of BDNF mRNA |
CTD |
PMID:8601816 PMID:31161640 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
EXP |
[Rolipram co-treated with Pentoxifylline] inhibits the reaction [Streptozocin results in increased cleavage of CASP3 protein]; Rolipram inhibits the reaction [Streptozocin results in increased cleavage of CASP3 protein] |
CTD |
PMID:37431890 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
multiple interactions |
EXP |
Rolipram inhibits the reaction [Manganese results in increased activity of CASP8 protein] |
CTD |
PMID:31161640 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
EXP |
Rolipram inhibits the reaction [Oxygen results in increased expression of CCL2 protein] |
CTD |
PMID:18941502 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
multiple interactions |
ISO |
Rolipram inhibits the reaction [Lipopolysaccharides results in increased expression of CCL3 mRNA]; Rolipram inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein] |
CTD |
PMID:9863660 |
|
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Cdh1 |
cadherin 1 |
multiple interactions increases expression |
ISO |
PDE4D protein inhibits the reaction [Rolipram results in increased expression of CDH1 protein] Rolipram results in increased expression of CDH1 mRNA; Rolipram results in increased expression of CDH1 protein |
CTD |
PMID:37020384 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
multiple interactions |
EXP |
Rolipram promotes the reaction [FSHB protein results in increased expression of CEBPB protein] |
CTD |
PMID:25253736 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cftr |
CF transmembrane conductance regulator |
multiple interactions increases activity decreases activity |
ISO |
Rolipram promotes the reaction [CFTR protein affects the secretion of Chlorides] Rolipram results in increased activity of CFTR protein Rolipram results in decreased activity of CFTR protein |
CTD |
PMID:12714375 PMID:15611099 |
|
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions increases phosphorylation increases expression |
EXP |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Rolipram promotes the reaction [Nitroprusside results in increased phosphorylation of CREB1 protein]]; Rolipram inhibits the reaction [Manganese results in decreased phosphorylation of CREB1 protein]; Rolipram promotes the reaction [Imipramine results in increased expression of CREB1 mRNA]; Rolipram promotes the reaction [Nitroprusside results in increased phosphorylation of CREB1 protein] Rolipram results in increased phosphorylation of CREB1 protein Rolipram results in increased expression of CREB1 mRNA |
CTD |
PMID:8601816 PMID:10908723 PMID:18276108 PMID:31161640 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
decreases secretion |
ISO |
Rolipram results in decreased secretion of CXCL10 protein |
CTD |
PMID:17996064 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
Rolipram inhibits the reaction [Atrazine inhibits the reaction [FSHB protein results in increased expression of CYP19A1 mRNA]] |
CTD |
PMID:28859905 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Edn1 |
endothelin 1 |
increases activity |
EXP |
Rolipram results in increased activity of EDN1 protein |
CTD |
PMID:15464066 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Epx |
eosinophil peroxidase |
multiple interactions |
EXP |
Rolipram inhibits the reaction [sephadex results in increased expression of EPX protein] |
CTD |
PMID:10850854 |
|
NCBI chr10:72,666,865...72,677,952
Ensembl chr10:72,666,865...72,677,952
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
multiple interactions |
EXP ISO |
Rolipram promotes the reaction [FSHB protein results in increased expression of CEBPB protein]; Rolipram promotes the reaction [FSHB protein results in increased expression of STAR mRNA] Rolipram inhibits the reaction [Atrazine inhibits the reaction [FSHB protein results in increased expression of CYP19A1 mRNA]]; Rolipram inhibits the reaction [Atrazine inhibits the reaction [FSHB protein results in increased expression of STAR mRNA]] |
CTD |
PMID:25253736 PMID:28859905 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
Il10 |
interleukin 10 |
decreases secretion |
ISO |
Rolipram results in decreased secretion of IL10 protein |
CTD |
PMID:9819297 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il13 |
interleukin 13 |
decreases expression decreases secretion |
ISO |
Rolipram results in decreased expression of IL13 mRNA Rolipram results in decreased secretion of IL13 protein |
CTD |
PMID:16083514 |
|
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
|
|
G |
Il18 |
interleukin 18 |
multiple interactions |
ISO |
Rolipram inhibits the reaction [Picryl Chloride results in increased expression of IL18 protein] |
CTD |
PMID:16442096 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO EXP |
Rolipram inhibits the reaction [Picryl Chloride results in increased expression of IL1B protein] Rolipram promotes the reaction [IL1B protein results in increased abundance of Cyclic AMP] Rolipram inhibits the reaction [Cyclophosphamide results in increased expression of IL1B mRNA] |
CTD |
PMID:8904084 PMID:16442096 PMID:18710439 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il4 |
interleukin 4 |
multiple interactions |
ISO |
Rolipram inhibits the reaction [Picryl Chloride results in increased expression of IL4 protein] |
CTD |
PMID:16442096 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
Rolipram inhibits the reaction [Picryl Chloride results in increased expression of IL6 protein] Rolipram promotes the reaction [TNF protein results in increased expression of IL6 mRNA] |
CTD |
PMID:16442096 PMID:24771768 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Itgam |
integrin subunit alpha M |
multiple interactions |
ISO |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Rolipram inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGAM protein]]; Rolipram inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGAM protein] |
CTD |
PMID:21457779 |
|
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
decreases activity |
ISO |
Rolipram results in decreased activity of KCNH2 protein |
CTD |
PMID:17146843 |
|
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
|
|
G |
Ltc4s |
leukotriene C4 synthase |
decreases secretion |
ISO |
Rolipram results in decreased secretion of LTC4S protein |
CTD |
PMID:16083514 |
|
NCBI chr10:34,560,476...34,562,790
Ensembl chr10:34,560,360...34,562,651
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
EXP |
[Colforsin co-treated with Rolipram co-treated with Picrotoxin] results in increased phosphorylation of MAPK1 protein; Dieldrin promotes the reaction [[Colforsin co-treated with Rolipram co-treated with Picrotoxin] results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:35137321 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
EXP |
[Colforsin co-treated with Rolipram co-treated with Picrotoxin] results in increased phosphorylation of MAPK3 protein; Dieldrin promotes the reaction [[Colforsin co-treated with Rolipram co-treated with Picrotoxin] results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:35137321 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression |
ISO |
PDE4D protein inhibits the reaction [Rolipram results in decreased expression of MMP9 protein] Rolipram results in decreased expression of MMP9 mRNA; Rolipram results in decreased expression of MMP9 protein |
CTD |
PMID:37020384 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
ISO EXP |
Rolipram inhibits the reaction [Picryl Chloride results in increased activity of MPO protein] Rolipram inhibits the reaction [Cyclophosphamide results in increased activity of MPO protein]; Rolipram inhibits the reaction [Indomethacin results in increased activity of MPO protein] |
CTD |
PMID:14567935 PMID:16442096 PMID:18710439 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
EXP |
Rolipram inhibits the reaction [Cyclophosphamide results in increased expression of NOS2 mRNA]; Rolipram inhibits the reaction [Cyclophosphamide results in increased expression of NOS2 protein] |
CTD |
PMID:18710439 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Ntrk2 |
neurotrophic receptor tyrosine kinase 2 |
increases expression multiple interactions |
EXP ISO |
Rolipram results in increased expression of NTRK2 mRNA Rolipram inhibits the reaction [NTRK2 protein binds to AP2M1 protein] |
CTD |
PMID:8601816 PMID:31631060 |
|
NCBI chr17:5,558,992...5,870,299
Ensembl chr17:5,559,043...5,869,136
|
|
G |
Pde4a |
phosphodiesterase 4A |
multiple interactions decreases activity |
ISO EXP |
[Albuterol co-treated with Rolipram] results in increased expression of PDE4A mRNA Rolipram results in decreased activity of PDE4A protein |
CTD |
PMID:10763856 PMID:15922051 PMID:31195342 |
|
NCBI chr 8:19,690,816...19,753,538
Ensembl chr 8:19,703,290...19,751,961
|
|
G |
Pde4b |
phosphodiesterase 4B |
multiple interactions decreases activity |
ISO EXP |
[Albuterol co-treated with Rolipram] results in increased expression of PDE4B mRNA Rolipram results in decreased activity of PDE4B protein Rolipram inhibits the reaction [Manganese results in increased expression of PDE4B protein] Rolipram inhibits the reaction [Lipopolysaccharides results in increased expression of PDE4B mRNA] |
CTD |
PMID:10763856 PMID:20384571 PMID:31161640 PMID:31195342 |
|
NCBI chr 5:116,799,819...117,369,155
Ensembl chr 5:116,799,971...117,367,696
|
|
G |
Pde4d |
phosphodiesterase 4D |
decreases expression multiple interactions |
ISO |
Rolipram results in decreased expression of PDE4D protein PDE4D protein inhibits the reaction [Rolipram results in decreased expression of MMP9 protein]; PDE4D protein inhibits the reaction [Rolipram results in decreased expression of TIMP1 protein]; PDE4D protein inhibits the reaction [Rolipram results in decreased expression of VIM protein]; PDE4D protein inhibits the reaction [Rolipram results in increased expression of CDH1 protein] |
CTD |
PMID:37020384 |
|
NCBI chr 2:40,014,933...41,529,190
Ensembl chr 2:40,019,933...41,525,884
|
|
G |
Rap1a |
RAP1A, member of RAS oncogene family |
multiple interactions |
EXP |
Rolipram affects the reaction [Colforsin results in increased activity of RAP1A protein] |
CTD |
PMID:10908723 |
|
NCBI chr 2:193,208,631...193,286,513
Ensembl chr 2:193,208,635...193,286,501
|
|
G |
Rap1b |
RAP1B, member of RAS oncogene family |
multiple interactions |
EXP |
Rolipram affects the reaction [Colforsin results in increased activity of RAP1B protein] |
CTD |
PMID:10908723 |
|
NCBI chr 7:53,423,039...53,456,349
Ensembl chr 7:53,423,130...53,456,370
|
|
G |
Rapgef3 |
Rap guanine nucleotide exchange factor 3 |
multiple interactions increases expression |
EXP |
RAPGEF3 mutant form inhibits the reaction [Rolipram results in increased phosphorylation of AKT1 protein] Rolipram results in increased expression of RAPGEF3 protein |
CTD |
PMID:18276108 |
|
NCBI chr 7:128,875,772...128,898,203
Ensembl chr 7:128,875,773...128,898,521
|
|
G |
Sele |
selectin E |
multiple interactions |
ISO |
[Colforsin co-treated with Rolipram] inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of SELE protein]; [Colforsin co-treated with Rolipram] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SELE protein]; [Colforsin co-treated with Rolipram] inhibits the reaction [TNF protein results in increased expression of SELE protein]; [Colforsin co-treated with Rolipram] inhibits the reaction [TNF protein results in increased secretion of SELE protein] |
CTD |
PMID:8780174 |
|
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
|
|
G |
Smad1 |
SMAD family member 1 |
decreases expression |
ISO |
Rolipram results in decreased expression of SMAD1 protein |
CTD |
PMID:37020384 |
|
NCBI chr19:28,513,130...28,573,665
Ensembl chr19:28,513,131...28,573,651
|
|
G |
Smad4 |
SMAD family member 4 |
decreases expression |
ISO |
Rolipram results in decreased expression of SMAD4 protein |
CTD |
PMID:37020384 |
|
NCBI chr18:67,243,742...67,274,438
Ensembl chr18:67,243,742...67,274,438
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
multiple interactions increases expression |
ISO |
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [[[Colforsin co-treated with Rolipram] results in increased abundance of Cyclic AMP] which results in increased expression of SOCS3 protein]; [[Colforsin co-treated with Rolipram] results in increased abundance of Cyclic AMP] which results in increased expression of SOCS3 protein; dorsomorphin inhibits the reaction [[[Colforsin co-treated with Rolipram] results in increased abundance of Cyclic AMP] which results in increased expression of SOCS3 protein] Rolipram results in increased expression of SOCS3 protein |
CTD |
PMID:23782265 |
|
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
multiple interactions |
EXP |
Rolipram inhibits the reaction [Oxygen results in increased expression of SPP1 mRNA]; Rolipram inhibits the reaction [Oxygen results in increased expression of SPP1 protein] |
CTD |
PMID:18941502 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Star |
steroidogenic acute regulatory protein |
multiple interactions |
EXP ISO |
Rolipram promotes the reaction [FSHB protein results in increased expression of STAR mRNA] Rolipram inhibits the reaction [Atrazine inhibits the reaction [FSHB protein results in increased expression of STAR mRNA]] |
CTD |
PMID:25253736 PMID:28859905 |
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
decreases secretion |
ISO |
Rolipram results in decreased secretion of TGFB1 protein |
CTD |
PMID:37020384 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
decreases expression multiple interactions |
ISO |
Rolipram results in decreased expression of TIMP1 mRNA; Rolipram results in decreased expression of TIMP1 protein PDE4D protein inhibits the reaction [Rolipram results in decreased expression of TIMP1 protein] |
CTD |
PMID:37020384 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions decreases secretion decreases expression |
ISO EXP |
Rolipram inhibits the reaction [[Lipopolysaccharides co-treated with deoxynivalenol] results in increased expression of TNF protein] [Colforsin co-treated with Rolipram] inhibits the reaction [TNF protein results in increased expression of SELE protein]; [Colforsin co-treated with Rolipram] inhibits the reaction [TNF protein results in increased secretion of SELE protein]; Rolipram inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Rolipram promotes the reaction [TNF protein results in increased expression of IL6 mRNA] Rolipram results in decreased secretion of TNF protein Rolipram results in decreased expression of TNF protein Rolipram inhibits the reaction [Cyclophosphamide results in increased expression of TNF mRNA] |
CTD |
PMID:8780174 PMID:8937731 PMID:9819297 PMID:11922776 PMID:15231041 PMID:18710439 PMID:24771768 More...
|
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Vim |
vimentin |
decreases expression multiple interactions |
ISO |
Rolipram results in decreased expression of VIM protein PDE4D protein inhibits the reaction [Rolipram results in decreased expression of VIM protein] |
CTD |
PMID:37020384 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|